We are excited to announce the keynote speakers for the 46th Annual National Convention. These individuals are leading medical practitioners and researchers in the field of hematology and sickle cell disease. We can all look forward to informative and interesting presentations from our three keynote speakers: Dr. M. Dawn Nelson, Dr. Russell Ware and Dr. Julie Kanter. Please see below for the presentation titles and the dates and times for their presentations.
Charles F. Whitten, MD Memorial Lecture – Friday, October 12, 2018
M. Dawn Nelson, PhD, CCC-A
We’ve Fallen But We Must Get Up: Dizziness, Falling and Hearing Loss in Individuals Living with Sickle Cell Disease
Dr. M. Dawn Nelson is an Associate Professor at Central Michigan University in the Department of Communication Sciences and Disorders, Doctor of Audiology (Au.D) Program. She received her Masters degree from the University of Maryland, her Ph.D. from Vanderbilt University, and completed a Post-Doctoral fellowship at the Johns Hopkins University Center for Hearing Sciences. Her teaching, clinical, and research interests include assessment and management of vestibular (balance) disorders, auditory-evoked potentials, neuroanatomy, and auditory processing disorders. More recently, Dr. Nelson’s research has explored imbalance, risk of falls, and hearing loss in individuals living with sickle cell disease.
M. Dawn Nelson, PhD, CCC-A
We’ve Fallen But We Must Get Up: Dizziness, Falling and Hearing Loss in Individuals Living with Sickle Cell Disease
Dr. M. Dawn Nelson is an Associate Professor at Central Michigan University in the Department of Communication Sciences and Disorders, Doctor of Audiology (Au.D) Program. She received her Masters degree from the University of Maryland, her Ph.D. from Vanderbilt University, and completed a Post-Doctoral fellowship at the Johns Hopkins University Center for Hearing Sciences. Her teaching, clinical, and research interests include assessment and management of vestibular (balance) disorders, auditory-evoked potentials, neuroanatomy, and auditory processing disorders. More recently, Dr. Nelson’s research has explored imbalance, risk of falls, and hearing loss in individuals living with sickle cell disease.
Clarice D. Reid, MD Lecture – Saturday, October 13, 2018
Russell Ware, MD, PhD
Global Strategies for Sickle Cell Disease
Dr. Russell Ware obtained his MD and Ph.D degrees at Duke University, completed his Pediatric Hematology/Oncology fellowship at Duke, and served as Director of the Duke Pediatric Sickle Cell Program until 2004. He then moved to St. Jude Children’s Research Hospital, serving as Chairman of Hematology before leading a sickle cell newborn screening program for the Republic of Angola. In July 2013, Dr. Ware joined Cincinnati Children’s Hospital Medical Center in Cincinnati Ohio as Director of Hematology and the Marjory Johnson Chair of Translational Hematology Research. He is also the Director of the Global Health Center.
Dr. Russell Ware obtained his MD and Ph.D degrees at Duke University, completed his Pediatric Hematology/Oncology fellowship at Duke, and served as Director of the Duke Pediatric Sickle Cell Program until 2004. He then moved to St. Jude Children’s Research Hospital, serving as Chairman of Hematology before leading a sickle cell newborn screening program for the Republic of Angola. In July 2013, Dr. Ware joined Cincinnati Children’s Hospital Medical Center in Cincinnati Ohio as Director of Hematology and the Marjory Johnson Chair of Translational Hematology Research. He is also the Director of the Global Health Center.
Special Lecture – Saturday, October 13, 2018
Julie Kanter, MD
Gene Therapy for Sickle Cell Disease: Fact or Fiction?
Gene Therapy for Sickle Cell Disease: Fact or Fiction?
Dr. Julie Kanter is a lifespan hematologist specializing in sickle cell disease. She is an associate professor of Pediatrics at the Medical University of South Carolina and runs the first all-ages, Lifespan Comprehensive Sickle Cell Center. Dr. Kanter works closely with national partners including the American Society of Hematology and NIH to improve the lives of individuals living with sickle cell disease. In 2016, Dr. Kanter and her team was awarded one of eight of the NHLBI sickle cell disease implementation grants to form a sickle cell implementation center. Dr. Kanter is also very interested in expanding access to care for patients with sickle cell disease through the statewide program (SC)2.